Optimal myocardial preservation: Cooling, cardioplegia, and conditioning

Annals of Thoracic Surgery

Volumn 61, Issue 2, 1996, Pages 760-768

  Cleveland Jr , Joseph C ^a   Meldrum, Daniel R ^a   Rowland, Robert T ^a   Banerjee, Anirban ^a   Harken, Alden H ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPLEGIA; COOLING; HEART PRESERVATION; HEART PROTECTION; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030059711     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(95)01129-3     Document Type: Review

References (75)

1. Cooley DA, Reul GJ, Wukasch DC. Ischemic contracture of the heart: "stone heart." Am J Cardiol 1972;29:575-7.
2. Jennings RB, Hawkins HK, Lowe JE, Hill ML, Klotman S, Reimer KA. Relation between high energy phosphate and lethal injury in myocardial ischemia in the dog. Am J Pathol 1978;92:187-214.
3. Najafi H, Henson D, Dye WS, et al. Left ventricular hemorrhagic necrosis. Ann Thorac Surg 1969;7:550-61.
4. Hottenrott CE, Towers B, Kurkji HJ, Maloney JV, Buckberg G. The hazard of ventricular fibrillation in hypertrophied ventricles during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1973;66:742-53.
5. Bigelow WG, Lindsay WK, Greenwood WF. Hypothermia its possible role in cardiac surgery: an investigation of factors governing survival in dogs at low body temperatures. Ann Surg 1950;132:849-66.
6. Shumway NE, Eovver RR. Topical cardiac hypothermia for extended periods of anoxic arrest. Surg Forum 1959;10:563-6.
7. Sonnenblick EH, Ross J Jr, Braunwald E. Oxygen consumption of the heart. Newer concepts of its multifactoral determination. Am J Cardiol 1968;22:328-36.
8. Buckberg CD, Brazier JR, Nelson RL, Goldstein SM, McConnell DH, Cooper N. Studies of the effects of hypothermia on regional myocardial blood flow and metabolism during cardiopulmonary bypass. I. The adequately perfused beating, fibrillating, and arrested heart. J Thorac Cardiovasc Surg 1977;73:87-94.
9. Conti VR, Bertranou EG, Blackstone EH, Kirklin JW, Digerness SB. Cold cardioplegia versus hypothermia for myocardial protection. J Thorac Cardiovasc Surg 1978;76:577-89.
10. Roe BB, Hutchinson JC, Fishman NH, Ullyot DJ, Smith DL. Myocardial protection with cold, ischemic, potassium-induced cardioplegia. J Thorac Cardiovasc Surg 1977;73: 366-74.
11. Cohen NM, Wise RM, Wechsler AS, Damiano RJ Jr. Elective cardiac arrest with a hyperpolarizing adenosine triphosphate-sensitive potassium channel opener. A novel form of myocardial protection? J Thorac Cardiovasc Surg 1993;106: 317-28.
12. Dawson JT, Hall RJ, Hallman GL, Cooley DA. Mortality in patients undergoing coronary artery bypass surgery after myocardial infarction. Am J Cardiol 1974;33:483-6.
13. Sink JD, Pellom GL, Currie WD, et al. Response of hypertrophied myocardium to ischemia. Correlation with biochemical and physiological parameters. J Thorac Cardiovasc Surg 1981;81:865-72.
14. Rosenkranz ER, Vinten-Johansen J, Buckberg GD, Okamato F, Edwards H, Bugyi H. Benefits of normothermic induction of blood cardioplegia in energy-depleted hearts, with maintenance of arrest by multidose cold blood cardioplegic infusions. J Thorac Cardiovasc Surg 1982;84:667-77.
15. Tixier D, Matheis G, Buckberg GD, Young HH. Donor hearts with impaired hemodynamics. Benefit of warm substrate-enriched blood cardioplegic solution for induction of cardioplegia during cardiac harvesting. J Thorac Cardiovasc Surg 1991;102:207-14.
16. Lichtenstein SV, Ashe KA, El Dalati H, Cusimano RJ, Panos A, Slutsky AS. Warm heart surgery. J Thorac Cardiovasc Surg 1991;101:269-74.
17. Teoh KH, Christakis GT, Weisel RD, et al. Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia. J Thorac Cardiovasc Surg 1986;91:888-95.
18. Martin TD, Craver JM, Gott JP, et al. Prospective, randomized trial of retrograde warm blood cardioplegia: myocardial benefit and neurologic threat. Ann Thorac Surg 1994;57: 298-304.
19. Naylor CD, Lichtenstein SV, Fremes SE, Warm Heart Investigators. Randomised trial of normothermic versus hypothermic coronary bypass surgery. Lancet 1994;343:559-63.
20. Buckberg GD. Update on current techniques of myocardial protection. Ann Thorac Surg 1995;60:805-14.
21. Wilkie DR. Generation of protons by metabolic processes other than glycolysis in muscle cells: a critical view. J Mol Cell Cardiol 1979;11:325-30.
22. Gevers W. Generation of protons by metabolic processes in heart cells. J Mol Cell Cardiol 1977;9:867-74.
23. Orchard CH, Kentish JC. Effects of changes of pH on the contractile function of cardiac muscle. Am J Physiol 1990;258 (Cell Physiol 27):C967-81.
24. Rovetto MJ, Lamberton WF, Neely JR. Mechanisms of glycolytic inhibition in ischemic rat hearts. Circ Res 1975;37: 742-51.
25. Fry CH, Poole-Wilson PA. Effects of acid base changes on excitation-contraction coupling in guinea-pig and rabbit cardiac ventricular muscle. J Physiol 1981;313:141-60.
26. Takach TJ, Glassman LR, Ribakove GH, Clark RE. Continuous measurement of intramyocardial pH: correlation to functional recovery following normothermic and hypothermic global ischemia. Ann Thorac Surg 1986;42:31-6.
27. Barner HB. Blood cardioplegia: a review and comparison with crystalloid cardioplegia. Ann Thorac Surg 1991;52: 1354-67.
28. Tait GA, Booker PD, Wilson GJ, Coles JG, Steward DJ, MacGregor DC. Effect of multidose cardioplegia and cardioplegic solution buffering on myocardial tissue acidosis. J Thorac Cardiovasc Surg 1982;83:824-9.
29. Neethling WML, van den Heever JJ, Cooper S, Meyer JM. Interstitial pH during myocardial preservation: assessment of five methods of myocardial preservation. Ann Thorac Surg 1993;55:420-6.
30. Shen AC, Jennings RB. Myocardial calcium and magnesium in acute ischemic injury. Am J Pathol 1972;67:417-40.
31. Steenbergen C, Fralix TA, Murphy E. Role of increased cytosolic free calcium concentration in myocardial ischemic injury. Basic Res Cardiol 1993;88:456-70.
32. +2 modulation during postischemic reperfusion in rat heart. Am J Physiol 1995;268 (Heart Circ Physiol 37):H100-11.
33. Lo HM, Kloner RA, Braunwald E. Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: critical importance of the timing of treatment. Am J Cardiol 1985;56:672-7.
34. Christakis GT, Fremes SE, Weisel RD, et al. Diltiazem cardioplegia. A balance of risk and benefit. J Thorac Cardiovasc Surg 1986;91:647-61.
35. Kitakaze M, Weisfeldt ML, Marban E. Acidosis during early reperfusion prevents myocardial stunning in perfused ferret hearts. J Clin Invest 1988;82:920-7.
36. Brown PS Jr, Holland FW, Parenteau GL, Clark RE. Magnesium ion is beneficial in hypothermic crystalloid cardioplegia. Ann Thorac Surg 1991;51:359-67.
37. Caspi J, Rudis E, Bar I, Safadi T, Saute M. Effects of magnesium on myocardial function after coronary artery bypass grafting. Ann Thorac Surg 1995;59:942-7.
38. Brown JM, Grosso MA, Terada LS, et al. Erythrocytes decrease myocardial hydrogen peroxide levels and reperfusion injury. Am J Physiol 1989;256 (Heart Circ Physiol 25):H584-8.
39. Julia PL, Buckberg GD, Acar C, Partington MT, Sherman MP. Studies of controlled reperfusion after ischemia. XXI. Reperfusate compositions: superiority of blood cardioplegia over crystalloid cardioplegia in limiting reperfusion damage - importance of endogenous oxygen free radical scavengers in red blood cells. J Thorac Cardiovasc Surg 1991;101: 303-13.
40. Buckberg GD. Oxygenated cardioplegia: blood is a many splendored thing. Ann Thorac Surg 1990;50:175-7.
41. Vinten-Johansen J, Chiantella V, Faust KB, et al. Myocardial protection with blood cardioplegia in ischemically injured hearts: reduction of reoxygenation injury with allopurinol. Ann Thorac Surg 1988;45:319-26.
42. Menasché P, Grousset C, Gauduel Y, Mouas C, Piwnica A. Prevention of hydroxyl radical formation: a critical concept for improving cardioplegia. Circulation 1987;76(Suppl 5): 180-5.
43. Drossos G, Lazou A, Panagopoulos P, Westaby S. Deferoxamine cardioplegia reduces superoxide radical production in human myocardium. Ann Thorac Surg 1995;59:169-72.
44. Morita K, Ihnken K, Buckberg GD, Sherman MP, Young HH, Ignarro LJ. Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts. J Clin Invest 1994;93: 2658-66.
45. Rau EE, Shine KI, Gervais A, Douglas AM, Amos EC III. Enhanced mechanical recovery of anoxic and ischemic myocardium by amino acid perfusion. Am J Physiol 1979;236 (Heart Circ Physiol 5):H873-9.
46. Lazar HL, Buckberg GD, Manganaro AM, Becker H. Myocardial energy replenishment and reversal of ischemic damage by substrate enhancement of secondary blood cardioplegia with amino acids during reperfusion. J Thorac Cardiovasc Surg 1980;80:350-9.
47. Engelman RM, Rousou JA, Flack JE III, Iyengar J, Kimura Y, Das DK. Reduction of infarct size by systemic amino acid supplementation during reperfusion. J Thorac Cardiovasc Surg 1991;101:855-9.
48. Beyersdorf F, Kirsh M, Buckberg GD, Allen BS. Warm glutamate/aspartate-enriched blood cardioplegic solution for perioperative sudden death. J Thorac Cardiovasc Surg 1992;104:1141-7.
49. Abd-Elfattah AS, Jessen ME, Wechsler AS. Nucleoside trapping during reperfusion prevents ventricular dysfunction, "stunning," in absence of adenosine. Possible separation between ischemic and reperfusion injury. J Thorac Cardiovasc Surg 1994;108:269-78.
50. Fiore AC, Naunheim KS, Taub J, et al. Myocardial preservation using lidocaine blood cardioplegia. Ann Thorac Surg 1990;50:771-5.
51. Bleese N, Doring V, Kalmar P, et al. Intraoperative myocardial protection by cardioplegia in hypothermia. Clinical findings. J Thorac Cardiovasc Surg 1978;75:405-13.
52. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
53. 1 adenosine receptors in rabbit heart. Circulation 1991;84:350-6.
54. Schott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990;66:1133-42.
55. 1-adrenergic mechanism. Circ Res 1993; 73:656-70.
56. Ikonomidis JS, Tumiati LC, Weisel RD, Mickle DAG, Li R-K. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischaemia. Cardiovasc Res 1994; 28:1285-91.
57. Walker DM, Walker JM, Pugsley WB, Pattison CW, Yellon DM. Preconditioning in isolated superfused human muscle. J Mol Cell Cardiol 1995;27:1349-57.
58. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993;342:276-7.
59. Shiki K, Hearse DJ. Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol 1987; 253 (Heart Circ Physiol 22):H1470-6.
60. Steenbergen C, Perlman ME, London RE, Murphy E. Mechanism of preconditioning: ionic alterations. Circ Res 1993;72: 112-25.
61. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW Jr, Herrmann HC, Laskey WK. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical, hemodynamic, and metabolic features. Circulation 1990;82: 2044-51.
62. Kloner RA, Shook T, Przyklenk K, et al. Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation 1995;91:37-47.
63. Ottani F, Galvani M, Ferrini D, et al. Prodromal angina limits infarct size a role for ischemic preconditioning. Circulation 1995;91:291-7.
64. 1-receptor mediated protection of the globally ischemic isolated rat heart. J Mol Cell Cardiol 1990;22:39-47.
65. Minisi AJ, Thames MD. Activation of cardiac sympathetic afferents during coronary occlusion evidence for reflex activation of sympathetic nervous system during transmural myocardial ischemia in the dog. Circulation 1991;84:357-67.
66. Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 1995;76:73-81.
67. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 1994;75:576-85.
68. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res 1994;75:586-90.
69. Movsesian MA, Nishikawa M, Adelstein RS. Phosphorylation of phospholamban by calcium-activated, phospholipid-dependent protein kinase: stimulation of cardiac sarcoplasmic reticulum calcium uptake. J Biol Chem 1984;259:8029-32.
70. +2 in isolated mammalian ventricular myocytes. J Physiol 1991;444:481-98.
71. Venema RC, Kuo JF. Protein kinase C-mediated phosphorylation of troponin I and C-protein in isolated myocardial cells is associated with inhibition of myofibrillar actomyosin MgATPase. J Biol Chem 1993;268:2705-11.
72. De Jong JW, van der Meer P, van Loon H, Owen P, Opie LH. Adenosine as adjunct to potassium cardioplegia: effect on function, energy metabolism, and electrophysiology. J Thorac Cardiovasc Surg 1990;100:445-54.
73. Lasley RD, Mentzer RM Jr. The role of adenosine in extended myocardial preservation with the University of Wisconsin solution. J Thorac Cardiovasc Surg 1994;107:1356-63.
74. Fremes SE, Zhang J, Furukawa RD, Mickle DAG, Weisel RD. Adenosine pretreatment for prolonged cardiac storage an evaluation with St. Thomas' Hospital and University of Wisconsin solutions. J Thorac Cardiovasc Surg 1995;110: 293-301.
75. Kolocassides KG, Galinanes M, Hearse DJ. Ischemic preconditioning, cardioplegia, or both? J Mol Cell Cardiol 1994;26: 1411-4.